Nicolas Lanthier

A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis

Stephen A. Harrison, Pierre Bédossa, Cynthia D. Guy et al. · New England Journal of Medicine · 2024 · 1.4K citations · Full text

A Randomized, Controlled Trial of the Pan-PPAR Agonist Lanifibranor in NASH

Sven Francque, Pierre Bédossa, Vlad Ratziu et al. · New England Journal of Medicine · 2021 · 655 citations · Full text

Expression of miR-33 from an SREBP2 Intron Inhibits Cholesterol Export and Fatty Acid Oxidation*

Isabelle Gerin, Laure‐Alix Clerbaux, Olivier Haumont et al. · Journal of Biological Chemistry · 2010 · 371 citations · Full text

Intronic Mirna, Lipid Peroxidation, Oxidative Stress +16

Kupffer cell activation is a causal factor for hepatic insulin resistance

Nicolas Lanthier, Olivier Molendi‐Coste, Yves Horsmans et al. · American Journal of Physiology-Gastrointestinal and Liver Physiology · 2009 · 250 citations

Kupffer Cell Activation, Immunology, Immune Regulation +24

SARS-CoV-2 causes a specific dysfunction of the kidney proximal tubule

Alexis Wérion, Leïla Belkhir, Marie Perrot et al. · Kidney International · 2020 · 231 citations · Full text

Glomerulonephritis, Urology, Renal Function +10